Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil Long-term Safety in Drug-resistant Focal Epilepsy (China Extension of Prior PSL Study)
CTR20200566Phase 2Suspended
- Sponsor
- UCB
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of padsevonil in Focal Onset Epilepsy, sponsored by UCB. Started Apr 2020; status: suspended.
02
Drugs
padsevonil
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on CTR20200566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200566.